Our company has a specialized translational medicine platform to offer a variety of effective services for various types of pharmaceutical firms, various types of medications, and projects at various stages of development.
We have a skilled technical team that can develop a range of bioanalytical techniques based on the discovery and validation of biomarkers, from the mechanism of action of drug targets and clinical application of biomarkers, in combination with a variety of technical platforms and state-of-the-art technical tools, to cut the expense and duration of drug development.
Our Translational Medicine Platform
Therapeutic tools have evolved from small molecules to new technology sectors such as peptides, proteins, antibodies, gene therapy, and cell treatment with the continual development of multi-omics analytical techniques like genomics, proteomics, and metabolomics. The etiology of many diseases is still not fully known despite the development of these modern technologies.
Translational medicine accelerates basic research, novel medication development, and clinical translation while acting as a gas pedal for precision-targeted medicines. It does this by converting biomedical observations and research into interventions to enhance health.
Through a variety of research methods, Our company's translational medicine research establishes the link between disease development and targets, explores the mechanism of action of medications, identifies the most appropriate populations and indications for clinical studies, and increases the effectiveness and success of new drug development. Our translational medicine platform focuses on biomarkers in the drug development process and aims to improve the clinical response rate of drug development through precision medicine. We aim to discover or validate new targets with clinical translational value and reveal new biological mechanisms of disease pathogenesis, drug action and drug resistance.
It covers from early target identification - preclinical development - clinical phase I, II, and III development, to post-marketing drug testing, through different stages of research to achieve a closed loop of drug development.
| Biomarker Discovery and Validation |
| Comprehensive biospecimen and preparation technology | - Blood, Bone.
- Tissue, Paraffin-embedded.
- Cells, Tumor cells.
- Liquid biopsy, CDNA, CTC, Exosomes.
|
| Multi-omics based biomarker and target research | Genomics, epigenomics, transcriptomics, miRNAomics, proteomics, patronymics, and cytomics. |
| Comprehensive translational medicine full platform | - Nucleic acids: qPCR, ddPCR.
- Sequencing: Sanger, PyroSeq, NGS.
- Protein: ELISA, WB, MSD, PK/ADA.
- Pathology: IHC & mIHC.
- Cell: Flow Cytometry, CTCs.
|
| Molecular pathology diagnostic techniques | - PCR technology: qPCR, ddPCR.
- Sequencing technology: Sanger, PyroMark, NGS, Single-cell.
- Protein technology: ELISA, CL.
- Pathology technology: Al & Remote diag, FISH, Leica/ Roche.
- Cytotechnology: CTCS, Cell-based Assay.
|
The platform services include:
Advantages of Our company's Translational Medicine Platform
Our company has a highly skilled R&D management team as well as an integrated translational medicine platform based on genomes, proteomics, cytomics, and pathology. Our translational medicine platform is committed to offering our global partners complete target integration solutions for the development of companion diagnostics, point-of-care validation, biomarker identification, and commercial testing.
- We used ELISA, SIMOA (HD-X), ECL (MSD), and Biacore 8K technologies to create our platform for protein interactions and protein-level biomarkers.
- We have platforms for polynucleic acid level biomarkers built using fluorescent quantitative PCR technology.
- We have platforms for pathology-level biomarkers built using immunohistochemistry (TAMs-IHC, FISH).
- We have platforms for flow cytometry-based cellular-level biomarker platforms (BD Symphony A3, BD Fortessa, Beckman CytoFLEX S).
- We are devoted to overcoming the challenges of cutting-edge medication development and advancing precision medicine.
For more information, please feel free to contact us.
Related Services
It should be noted that our service is only used for research, not for clinical use.
